Technology
Health
Medical

Soleno Therapeutics

875

$2.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.79%) As of 3:45 PM EDT today
-$0.04 (-1.79%) Today

Why Robinhood?

You can buy or sell SLNO and other stocks, options, ETFs, and crypto commission-free!

About SLNO

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The company focuses on the treatment of metabolic and neurobehavioral disorder. Read More It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

CEO
Anish Bhatnagar
Employees
25
Headquarters
Redwood City, California
Founded
1999
Market Cap
110.38M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
79.70K
High Today
$2.49
Low Today
$2.15
Open Price
$2.20
Volume
129.76K
52 Week High
$4.11
52 Week Low
$1.18

Collections

Technology
Health
Medical
Therapy
2014 IPO
US
North America

SLNO Earnings

-$0.36
-$0.23
-$0.10
$0.03
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 11, After Hours

People Also Bought

Sorrento Therapeutics

17,075

$2.54

+2.42%

Sorrento Therapeutics

17,075

$2.54

+2.42%

Oragenics

53,313

$0.5835

+6.21%

SCYNEXIS

13,796

$0.85

+4.94%

BioPharmX

23,625

$0.265

-1.27%

You May Also Like

GAZ
AIMC
SNCA
EFR
VMOT
IVR-B
PLX
SHG
INGN
BAP
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy SLNO

Market Price$2.20
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell SLNO stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up